Expression of PEF1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

PEF1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 91.46

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

78.1

Number of samples

141

Samples

Sample	Description	TPM
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	190.1
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	162.9
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	139.3
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	113.0
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	111.4
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	109.0
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	108.9
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	107.4
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	107.4
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	106.6
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	106.2
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	103.2
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	101.9
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	99.7
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	98.4
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	97.5
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	97.3
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	97.1
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	96.9
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	96.1
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	95.5
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	94.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	94.1
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	94.1
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	93.5
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	92.0
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	91.9
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	91.8
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	91.8
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	91.7
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	91.2
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	90.8
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	90.8
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	89.6
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	88.9
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	88.8
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	88.5
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	87.5
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	87.4
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	86.8
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	86.3
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	86.2
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	86.1
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	85.4
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	85.2
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	84.8
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	84.7
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	84.4
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	83.7
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	83.6
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	83.4
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	83.0
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	82.6
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	82.4
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	81.9
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	81.4
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	80.2
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	79.8
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	79.5
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	79.4
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	79.2
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	78.5
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	78.3
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	77.9
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	77.6
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	77.6
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	77.5
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	77.3
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	77.3
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	77.3
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	77.2
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	77.1
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	76.9
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	76.6
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	76.6
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	76.2
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	75.8
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	74.9
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	74.8
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	74.4
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	74.3
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	74.3
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	74.2
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	74.1
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	74.0
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	73.7
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	73.7
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	73.4
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	73.2
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	72.8
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	71.5
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	71.3
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	71.2
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	71.1
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	71.1
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	70.6
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	69.4
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	69.0
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	68.8
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	68.5
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	67.7
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	66.6
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	66.5
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	66.3
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	66.3
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	65.7
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	65.5
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	65.1
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	65.1
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	64.8
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	64.6
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	64.4
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	64.0
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	63.1
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	62.8
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	62.5
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	62.3
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	62.1
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	61.1
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	60.8
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	60.0
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	59.7
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	58.4
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	57.1
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	56.6
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	56.3
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	54.9
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	51.7
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	50.7
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	48.9
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	47.5
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	47.5
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	47.4
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	47.1
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	46.2
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	44.8
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	40.5
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	40.4
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	38.4
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	36.6
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	25.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

PEF1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 13.65

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

14.6

Number of samples

Samples

Sample	Description	TPM
AK185	N, NA, stage:NA, alive, 330 days	20.4
AK216	N, NA, stage:NA, dead, 360 days	20.2
AK123	N, NA, stage:NA, dead, 180 days	20.0
AK051	N, NA, stage:NA, dead, 360 days	18.8
AK043	N, NA, stage:NA, alive, 660 days	18.7
AK134	N, NA, stage:NA, dead, 360 days	18.7
AK002	N, NA, stage:NA, dead, 570 days	18.4
AK178	N, NA, stage:NA, dead, 240 days	18.2
AK124	N, NA, stage:NA, alive, 1920 days	17.4
AK188	N, NA, stage:NA, alive, 420 days	17.2
AK183	N, NA, stage:NA, alive, 360 days	17.1
AK055	N, NA, stage:NA, dead, 240 days	16.8
AK227	N, NA, stage:NA, alive, 300 days	16.7
AK041	N, NA, stage:NA, alive, 810 days	16.3
AK072	N, NA, stage:NA, dead, 150 days	16.2
AK231	N, NA, stage:NA, dead, 240 days	15.7
AK100	N, NA, stage:NA, alive, 960 days	15.6
AK165	N, NA, stage:NA, alive, 360 days	15.5
AK195	N, NA, stage:NA, dead, 390 days	15.5
AK117	N, NA, stage:NA, dead, 210 days	15.4
AK142	N, NA, stage:NA, alive, 90 days	15.4
AK076	N, NA, stage:NA, alive, 660 days	15.3
AK236	N, NA, stage:NA, dead, 360 days	15.2
AK088	N, NA, stage:NA, dead, 360 days	15.2
AK098	N, NA, stage:NA, dead, 660 days	15.0
AK133	N, NA, stage:NA, dead, 360 days	14.9
AK074	N, NA, stage:NA, alive, 300 days	14.9
AK213	N, NA, stage:NA, alive, 2010 days	14.6
AK167	N, NA, stage:NA, dead, 180 days	14.6
AK035	N, NA, stage:NA, dead, 210 days	14.6
AK199	N, NA, stage:NA, alive, 1860 days	14.3
AK085	N, NA, stage:NA, alive, 660 days	14.2
AK173	N, NA, stage:NA, dead, 180 days	14.2
AK071	N, NA, stage:NA, dead, 540 days	14.0
AK156	N, NA, stage:NA, dead, 330 days	13.8
AK015	N, NA, stage:NA, alive, 720 days	13.7
AK066	N, NA, stage:NA, alive, 960 days	13.7
AK226	N, NA, stage:NA, dead, 360 days	13.6
AK158	N, NA, stage:NA, dead, 360 days	13.6
AK091	N, NA, stage:NA, dead, 210 days	13.4
AK218	N, NA, stage:NA, dead, 180 days	13.4
AK081	N, NA, stage:NA, dead, 180 days	13.2
AK089	N, NA, stage:NA, dead, 330 days	12.9
AK068	N, NA, stage:NA, alive, 360 days	12.8
AK030	N, NA, stage:NA, dead, 120 days	12.8
AK003	N, NA, stage:NA, dead, 600 days	12.6
AK079	N, NA, stage:NA, dead, 210 days	12.6
AK099	N, NA, stage:NA, dead, 420 days	12.4
AK103	N, NA, stage:NA, alive, 1320 days	12.2
AK205	N, NA, stage:NA, dead, 120 days	12.1
AK053	N, NA, stage:NA, dead, 300 days	12.1
AK153	N, NA, stage:NA, dead, 240 days	12.1
AK006	N, NA, stage:NA, dead, 360 days	11.6
AK005	N, NA, stage:NA, dead, 240 days	11.5
AK149	N, NA, stage:NA, dead, 420 days	11.0
AK102	N, NA, stage:NA, alive, 1740 days	10.7
AK049	N, NA, stage:NA, dead, 180 days	10.1
AK139	N, NA, stage:NA, dead, 270 days	9.2
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0204400003	Normal	0.6
CPT0207090003	Tumor	0.6
CPT0204330003	Normal	0.5
CPT0002410011	Tumor	0.4
CPT0204390003	Normal	0.4
CPT0201710003	Tumor	0.4
CPT0204340003	Normal	0.4
CPT0204420003	Normal	0.4
CPT0204350003	Normal	0.4
CPT0125570003	Tumor	0.4
CPT0189750004	Tumor	0.4
CPT0218670003	Tumor	0.4
CPT0204370003	Normal	0.4
CPT0224600003	Tumor	0.4
CPT0204360003	Normal	0.3
CPT0218330004	Tumor	0.3
CPT0093550003	Tumor	0.3
CPT0207030003	Tumor	0.3
CPT0206670004	Tumor	0.3
CPT0125510003	Tumor	0.3
CPT0206330003	Tumor	0.3
CPT0206230003	Tumor	0.3
CPT0071100003	Tumor	0.3
CPT0224390004	Tumor	0.2
CPT0167750004	Tumor	0.2
CPT0168590003	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0175060003	Tumor	0.2
CPT0204410003	Normal	0.2
CPT0092440003	Tumor	0.2
CPT0182500003	Tumor	0.2
CPT0167530003	Tumor	0.2
CPT0167970003	Tumor	0.2
CPT0162100003	Tumor	0.2
CPT0182580003	Tumor	0.2
CPT0186100003	Tumor	0.2
CPT0206450003	Tumor	0.2
CPT0104220003	Tumor	0.1
CPT0190240004	Tumor	0.1
CPT0219080004	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0224540004	Tumor	0.1
CPT0162140003	Tumor	0.1
CPT0216920008	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0217710008	Tumor	0.1
CPT0205570003	Tumor	0.1
CPT0217880003	Tumor	0.1
CPT0189250003	Tumor	0.1
CPT0087950003	Tumor	0.1
CPT0204380003	Normal	0.1
CPT0196850003	Tumor	0.1
CPT0225730003	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0225760003	Tumor	0.0
CPT0221180003	Tumor	0.0
CPT0217190003	Tumor	0.0
CPT0218890004	Tumor	0.0
CPT0127480003	Tumor	0.0
CPT0206780003	Tumor	0.0
CPT0199770003	Tumor	0.0
CPT0093590003	Tumor	0.0
CPT0218830004	Tumor	0.0
CPT0093360003	Tumor	0.0
CPT0217430008	Tumor	0.0
CPT0209440003	Tumor	0.0
CPT0168080003	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0064650003	Tumor	0.0
CPT0161730003	Tumor	0.0
CPT0189570004	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0205450004	Tumor	0.0
CPT0104330003	Tumor	0.0
CPT0079790003	Tumor	0.0
CPT0182550003	Tumor	0.0
CPT0218960004	Tumor	0.0
CPT0217100003	Tumor	0.0
CPT0168480003	Tumor	0.0
CPT0123530003	Tumor	0.0
CPT0205890003	Tumor	-0.1
CPT0127420003	Tumor	-0.1
CPT0087680003	Tumor	-0.1
CPT0093450003	Tumor	-0.1
CPT0093510003	Tumor	-0.1
CPT0208980003	Tumor	-0.1
CPT0087730003	Tumor	-0.1
CPT0089150003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0190360004	Tumor	-0.1
CPT0189850004	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0167860004	Tumor	-0.2
CPT0162020003	Tumor	-0.2
CPT0078580003	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0218690004	Tumor	-0.2
CPT0206880003	Tumor	-0.2
CPT0171580008	Tumor	-0.2
CPT0205780003	Tumor	-0.2
CPT0206110003	Tumor	-0.3
CPT0087570003	Tumor	-0.3
CPT0228220003	Tumor	-0.3
CPT0218770003	Tumor	-0.4
CPT0217000004	Tumor	-0.4
CPT0189650004	Tumor	-0.5
CPT0206560003	Tumor	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis